A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity
Clinical trial NCT03261167 · COMPLETED
Trial details
- NCT number
- NCT03261167
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2018-03-20
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.